Single-cell analysis of CML patients bone marrow at diagnosis reveals coexistence of CD26-CD35+ healthy stem cells and CD26+CD35- CML stem cells, and how the ratio between these impacts TKI response.

Upon a pre-specified, interim analysis after nine months of treatment, the company said sibeprenlimab therapy was associated with a “statistically significant and clinically meaningful” reduction, ...

No. 2 North Dakota State won the 2024 Dakota Marker, defeating No. 1 South Dakota State 13-9. With the win, the Bison end a five-game losing streak to the Jackrabbits. North Dakota State ...

SMN2 is a biomarker for SMA severity but not for treatment response, highlighting the need for additional markers like TSP4. TSP4 levels increased after nusinersen therapy, indicating potential as ...

So far, several markers have been suggested, some of which are preferentially analyzed by flow cytometry and include CD38 and ZAP70, two molecules that have been extensively studied in CLL.